Maxcyte (MXCT) Other Working Capital Changes (2020 - 2026)
Maxcyte's (MXCT) quarterly Other Working Capital Changes came in at -$456000.0 in Q1 2026, down 64.03% year-on-year from -$1.3 million in Q1 2025, and down 109.17% on a QoQ basis from -$218000.0 in Q4 2025.
Maxcyte (MXCT) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Other Working Capital Changes data on file, last reported at -$456000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 64.03% year-over-year to -$456000.0 in Q1 2026; TTM through Mar 2026 was -$1.3 million, a 51.02% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 million, down 63.19% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$456000.0, down from -$218000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for MXCT reached as high as $2.0 million in Q3 2022 and fell as low as -$2.1 million in Q2 2022.
- Historically, Other Working Capital Changes has averaged -$84294.1 across 5 years, with a median of -$215000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 5600.73% in 2022 and fell as far as 183.74% in 2022.
- Year by year, Other Working Capital Changes stood at -$3.9 million in 2022, then surged by 96.89% to -$120000.0 in 2023, then slumped by 137.5% to -$285000.0 in 2024, then rose by 23.51% to -$218000.0 in 2025, then plunged by 109.17% to -$456000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$456000.0 in Q1 2026, -$218000.0 in Q4 2025, and -$346000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -456,000.00 |
| Mar 31, 2026 | -456,000.00 |
| Mar 31, 2026 | -456,000.00 |
| Dec 31, 2025 | -218,000.00 |
| Dec 31, 2025 | -218,000.00 |
| Dec 31, 2025 | -218,000.00 |
| Sep 30, 2025 | -346,000.00 |
| Sep 30, 2025 | -346,000.00 |
| Sep 30, 2025 | -346,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Dec 31, 2024 | -285,000.00 |
| Dec 31, 2024 | -285,000.00 |
| Dec 31, 2024 | -285,000.00 |
| Sep 30, 2024 | -209,000.00 |
| Sep 30, 2024 | -209,000.00 |